Inspire Medical (INSP)
NYSE:INSP
Want to see INSP full AI Analyst Report?
Total Valuation
Inspire Medical Systems has a market cap or net worth of $1.17B. The enterprise value is $1.12B.
Market Cap$1.17B
Enterprise Value$1.12B
Share Statistics
Inspire Medical Systems has 28,813,152 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,813,152
Owned by Insiders1.69%
Owned by Institutions36.55%
Financial Efficiency
Inspire Medical Systems’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 6.26%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)6.26%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee731.93K
Profits Per Employee116.71K
Employee Count1,246
Asset Turnover1.01
Inventory Turnover0.92
Valuation Ratios
The current PE Ratio of Inspire Medical Systems is 9.2. Inspire Medical Systems’s PEG ratio is 0.11.
PE Ratio9.2
PS Ratio2.97
PB Ratio3.47
Price to Fair Value3.47
Price to FCF34.52
Price to Operating Cash Flow8.87
PEG Ratio0.11
Income Statement
In the last 12 months, Inspire Medical Systems had revenue of 911.98M and earned 145.42M in profits. Earnings per share was 4.95.
Revenue911.98M
Gross Profit778.76M
Operating Income50.95M
Pretax Income65.70M
Net Income145.42M
EBITDA64.91M
Earnings Per Share (EPS)4.95
Cash Flow
In the last 12 months, operating cash flow was 136.53M and capital expenditures -39.82M, giving a free cash flow of 96.71M billion.
Operating Cash Flow136.53M
Free Cash Flow96.71M
Free Cash Flow per Share3.36
Dividends & Yields
Inspire Medical Systems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.67
52-Week Price Change-68.98%
50-Day Moving Average49.41
200-Day Moving Average75.73
Relative Strength Index (RSI)40.98
Average Volume (3m)1.30M
Important Dates
Inspire Medical Systems upcoming earnings date is Aug 4, 2026, After Close (Confirmed).
Last Earnings DateMay 4, 2026
Next Earnings DateAug 4, 2026
Ex-Dividend Date―
Financial Position
Inspire Medical Systems as a current ratio of 6.08, with Debt / Equity ratio of 3.73%
Current Ratio6.08
Quick Ratio4.56
Debt to Market Cap0.00
Net Debt to EBITDA-1.12
Interest Coverage Ratio371.93
Taxes
In the past 12 months, Inspire Medical Systems has paid -79.72M in taxes.
Income Tax-79.72M
Effective Tax Rate-1.21
Enterprise Valuation
Inspire Medical Systems EV to EBITDA ratio is 40.61, with an EV/FCF ratio of 33.59.
EV to Sales2.89
EV to EBITDA40.61
EV to Free Cash Flow33.59
EV to Operating Cash Flow22.53
Balance Sheet
Inspire Medical Systems has $283.83M in cash and marketable securities with $29.55M in debt, giving a net cash position of $254.28M billion.
Cash & Marketable Securities$283.83M
Total Debt$29.55M
Net Cash$254.28M
Net Cash Per Share$8.83
Tangible Book Value Per Share$26.60
Margins
Gross margin is 85.78%, with operating margin of 5.59%, and net profit margin of 15.95%.
Gross Margin85.78%
Operating Margin5.59%
Pretax Margin7.20%
Net Profit Margin15.95%
EBITDA Margin7.12%
EBIT Margin5.59%
Analyst Forecast
The average price target for Inspire Medical Systems is $52.40, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$52.40
Price Target Upside-9.01% Downside
Analyst ConsensusHold
Analyst Count12
Revenue Growth Forecast8.94%
EPS Growth Forecast102.92%